SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-007527
Filing Date
2023-01-27
Accepted
2023-01-27 16:10:18
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm234267d1_s3.htm S-3 391681
2 EXHIBIT 4.8 tm234267d1_ex4-8.htm EX-4.8 511063
3 EXHIBIT 5.1 tm234267d1_ex5-1.htm EX-5.1 35568
4 EXHIBIT 23.1 tm234267d1_ex23-1.htm EX-23.1 2674
5 EX-FILING FEES tm234267d1_ex-filingfees.htm EX-FILING FEES 72390
6 GRAPHIC tm234267d1_ex5-1img001.jpg GRAPHIC 2888
7 GRAPHIC tm234267d1_ex5-1img002.jpg GRAPHIC 2231
8 GRAPHIC tm234267d1_s3p2img001.jpg GRAPHIC 5077
  Complete submission text file 0001104659-23-007527.txt   1029041
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269440 | Film No.: 23562892
SIC: 2834 Pharmaceutical Preparations